MHC class II molecules control murine B cell responsiveness to lipopolysaccharide stimulation

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4620-4626

  Rodo, Joana ^a   Gonçalves, Lígia A ^a   Demengeot, Jocelyne ^a   Coutinho, António ^a   Penha Gonçalves, Carlos ^a  

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD180 ANTIGEN; CD19 ANTIGEN; CD69 ANTIGEN; IMMUNOGLOBULIN M; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CHROMOSOME 4; CONGENIC STRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; GENE; GENE MAPPING; HAPLOTYPE; HEREDITY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RP105 GENE; SPLEEN CELL; STATISTICAL ANALYSIS;

EID: 33749124149     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4620     Document Type: Article

References (41)

1. Rietschel, E. T., H. Brade, O. Holst, L. Brade, S. Muller-Loennies, U. Mamat, U. Zahringer, F. Beckmann, U. Seydel, K. Brandenburg, A. J. et al. 1996. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top Microbiol. Immunol. 216: 39-81.
2. Netea, M. G., M. van Deuren, B. J. Kullberg, J. M. Cavaillon, and J. W. Van der Meer. 2002. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol. 23: 135-139.
3. Rietschel, E. T., H. W. Wollenweber, U. Zahringer, and O. Luderitz. 1982. Lipid A, the lipid component of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Klin. Wochenschr. 60: 705-709.
4. Shahin, R. D., I. Engberg, L. Hagberg, and C. Svanborg Eden. 1987. Neutrophil recruitment and bacterial clearance correlated with LPS responsiveness in local Gram-negative infection. J. Immunol. 138: 3475-3480.
5. Ulevitch, R. J., and P. S. Tobias. 1999. Recognition of Gram-negative bacteria and endotoxin by the innate immune system. Curr. Opin. Immunol. 11: 19-22.
6. Rietschel, E. T., U. Schade, M. Jensen, H. W. Wollenweber, O. Luderitz, and S. G. Greisman. 1982. Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J. Infect. Dis. Suppl. 31: 8-21.
7. Abhishek, A., A. Anushree, T. Ashutosh, and S. Ray. 2005. Comment to: Septic shock: current pathogenic concept from a clinical perspective Tsiotou AG, Sakorafas GH, Anagnostopoulos G, Bramis J Med Sci Monit. 2005; 11 (3): RA76-RA85: future treatment perspectives in septic shock. Med Sci Monit. 11: LE22-LE23.
8. Coutinho, A., G. Moller, and E. Gronowicz. 1975. Genetical control of B-cell responses. IV. Inheritance of the unresponsiveness to lipopolysaccharides. J. Exp. Med. 142: 253-258.
9. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
10. Coutinho, A., L. Forni, F. Melchers, and T. Watanabe. 1977. Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur. J. Immunol. 7: 325-328.
11. Poltorak, A., I. Smirnova, X. He, M. Y. Liu, C. Van Huffel, O. McNally, D. Birdwell, E. Alejos, M. Silva, X. Du, et al. 1998. Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol. Dis. 24: 340-355.
12. Hoshino, K., O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira. 1999. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162: 3749-3752.
13. Kalis, C., B. Kanzler, A. Lembo, A. Poltorak, C. Galanos, and M. A. Freudenberg. 2003. Toll-like receptor 4 expression levels determine the degree of LPS-susceptibility in mice. Eur. J. Immunol. 33: 798-805.
14. Watson, J., K. Kelly, M. Largen, and B.A. Taylor. 1978. The genetic mapping of defective LPS response gene in C3H/HeJ mice. J. Immunol. 120: 422-424.
15. Janeway, C. A., Jr., and R. Medzhitov. 2002. Innate immune recognition. Annu. Rev. Immunol. 20: 197-216.
16. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol 4: 499-511.
17. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1: 135-145.
18. Wright, S. D., P. S. Tobias, R. J. Ulevitch, and R. A. Ramos. 1989. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages. J. Exp. Med. 170: 1231-1241.
19. Schumann, R. R., S. R. Leong, G. W. Flaggs, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249: 1429-1431.
20. da Silva Correiaqq, J., K. Soldau, U. Christen, P. S. Tobias, and R. J. Ulevitch. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276: 21129-21135.
21. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudome, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189: 1777-1782.
22. Akashi, S., R. Shimazu, H. Ogata, Y. Nagai, K. Takeda, M. Kimoto, and K. Miyake. 2000. Cutting edge: cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164: 3471-3475.
23. Ahmad-Nejad, P., H. Hacker, M. Rutz, S. Bauer, R. M. Vabulas, and H. Wagner. 2002. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32: 1958-1968.
24. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P. F. Muhlradt, S. Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167: 5887-5894.
25. Toshchakov, V., B. W. Jones, P. Y. Perera, K. Thomas, M. J. Cody, S. Zhang, B. R. Williams, J. Major, T. A. Hamilton, M. J. Fenton, and S. N. Vogel. 2002. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β- dependent gene expression in macrophages. Nat. Immunol. 3: 392-398.
26. Ogata, H., I. Su, K. Miyake, Y. Nagai, S. Akashi, I. Mecklenbrauker, K. Rajewsky, M. Kimoto, and A. Tarakhovsky. 2000. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192: 23-29.
27. Miyake, K., Y. Yamashita, M. Ogata, T. Sudo, and M. Kimoto. 1995. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154: 3333-3340.
28. Miyake, K., R. Shimazu, J. Kondo, T. Niki, S. Akashi, H. Ogata, Y. Yamashita, Y. Miura, and M. Kimoto. 1998. Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J. Immunol. 161: 1348-1353.
29. Kearney, J. F., and A. R. Lawton. 1975. B lymphocyte differentiation induced by lipopolysaccharide. I. Generation of cells synthesizing four major immunoglobulin classes. J. Immunol. 115: 671-676.
30. Forsgren, S., G. Pobor, A. Coutinho, and M. Pierres. 1984. The role of I-A/E molecules in B lymphocyte activation. I. Inhibition of lipopolysaccharide-induced responses by monoclonal antibodies. J. Immunol. 133: 2104-2110.
31. Wells, C. A., T. Ravasi, G. J. Faulkner, P. Carninci, Y. Okazaki, Y. Hayashizaki, M. Sweet, B. J. Wainwright, and D. A. Hume. 2003. Genetic control of the innate immune response. BMC Immunol. 4: 5.
32. Hirschfeld, M., Y. Ma, J. H. Weis, S. N. Vogel, and J. J. Weis. 2000. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J. Immunol. 165: 618-622.
33. Grandien, A., A. Coutinho, and J. Andersson. 1990. Selective peripheral expansion and activation of B cells expressing endogenous immunoglobulin in Mutransgenic mice. Eur. J. Immunol. 20: 991-998.
34. Sedgwick, J. D., and P. G. Holt. 1983. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57: 301-309.
35. Broman, K. W., H. Wu, S. Sen, and G. A. Churchill. 2003. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
36. Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11: 241-247.
37. Piani, A., J. P. Hossle, T. Birchler, C. A. Siegrist, D. Heumann, G. Davies, S. Loeliger, R. Seger, and R. P. Lauener. 2000. Expression of MHC class II molecules contributes to lipopolysaccharide responsiveness. Eur. J. Immunol. 30: 3140-3146.
38. Forsgren, S., A. C. Martinez, and A. Coutinho. 1987. The role of I-A/E molecules in B-lymphocyte activation. II. Mechanism of inhibition of the responses to lipopolysaccharide by anti-I-A/E antibodies. Scand. J. Immunol. 25: 225-234.
39. Santamaria, P., R. C. Gehrz, M. K. Bryan, and J. J. Barbosa. 1989. Involvement of class II MHC molecules in the LPS-induction of IL-1/TNF secretions by human monocytes: quantitative differences at the polymorphic level. J. Immunol. 143: 913-922.
40. Cobb, B. A., Q. Wang, A. O. Tzianabos, and D. L. Kasper. 2004. Polysaccharide processing and presentation by the MHCII pathway. Cell 117: 677-687.
41. Forestier, C., E. Moreno, S. Meresse, A. Phalipon, D. Olive, P. Sansonetti, and J. P. Gorvel. 1999. Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect. Immun. 67: 4048-4054.